Table 3: Summary of outcomes reported for atypical lipomas in select series.

AuthorYearNo. of patientsMean FU
(M)
LRDedifferentiation
(%) (%)

Evans et al. [12]1979229 (41%)0
Azumi et al. [7]198748847 (15)0
Weiss and Rao [8]19924610820 (46)3 (7)
Lucas et al. [9]19943211215 (47)6 (19)
Rozental et al. [13]2002318416 (52)2 (6)
Kooby et al. [3] 2004914720 (22)3 (3)
Bassett et al. [14] 2005515214 (27)1 (2)
Sommerville et al. [15]200561505 (8)0
Evans [5]200711a>1201 (9)0
Serpell and Chen [10]20076b183 (50)1 (17)
Billing et al. [4]200838904 (10)0
Mavrogenis et al. [6]201167815 (11)1 (2)

FU indicates follow-up, M: months, LR: local recurrence.
aExtremity lipomas only, batypical lipomas only.